Erlichman and his team reported that PD-L1 activates STAT1 and STAT3 to promote breast cancer cell metastasis both in vitro and in vivo and that PD-L1 is required for N-glycosylation at the N219 site [102]. Here, CD274 is linked to breast cancer.